OC
DVAX

Oppenheimer & Co’s Dynavax Technologies DVAX Stock Holding History

Oppenheimer & Co’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1,690
Closed -$30K – 1425
2014
Q1 		$30K Hold
1,690
– – ﹤0.01% 1384
2013
Q4 		$34K Sell
1,690
-8,810
-84% -$129K ﹤0.01% 1358
2013
Q3 		$125K Buy
10,500
+4,000
+62% +$50.3K ﹤0.01% 1227
2013
Q2 		$72K Buy
+6,500
New +$137K ﹤0.01% 1215

Other funds holding DVAX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Oppenheimer & Co's DVAX Position: Q2 2014 in Review

Oppenheimer & Co sold out of Dynavax Technologies (DVAX) in Q2 2014, closing a stake of 1,690 shares — an estimated $30K sold.

Oppenheimer & Co first reported a position in DVAX in Q2 2013 and held it in 4 quarters. The position peaked at $125K in Q3 2013. 117 funds tracked by Wall St. Rank hold DVAX as of Q2 2014.

  • Oppenheimer & Co reported no remaining Dynavax Technologies position as of Q2 2014 after selling out during the quarter.
  • Oppenheimer & Co sold 1,690 Dynavax Technologies shares in Q2 2014, an estimated $30K.
  • Oppenheimer & Co first reported a position in Dynavax Technologies in Q2 2013 and held it in 4 quarters.
  • Oppenheimer & Co's Dynavax Technologies position peaked at $125K in Q3 2013.
  • 117 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2014.

Based on Oppenheimer & Co's 13F filing for Q2 2014, filed 14 Aug 2014.